PubMed Health⌕ Search

PubMed · 6822167

The left transverse colostomy.

Abstract

The right transverse colostomy is the one traditionally performed for distal colonic obstructive tumors, perforated sigmoid diverticulitis, distal colonic injuries, or for the protection of precarious low colonic anastomoses. However, the right transverse colostomy has a tendency to prolapse; its effluent is frequently liquid; it cannot be performed without producing adhesions in the right upper quadrant; and it obligates the surgeon generally to three operations when done as the first part of a staged colonic resection. The left transverse colostomy has the advantages of a reduced incidence of prolapse, an increased length of absorptive surface, absence of adhesions in the right upper quadrant, and the possibility of a two-stage resection. Fifteen instances in which left transverse colostomies were performed with diverse indications formed the basis for this report.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

L Morgenstern, S L Michel. 1983. The left transverse colostomy.. https://doi.org/10.1007/bf02562584

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Crohn's disease.

Crohn's disease is a relapsing systemic inflammatory disease, mainly affecting the gastrointestinal tract with extraintestinal manifestations and associated immune disorders. Genome wide association studies identified susceptibility loci that--triggered by environmental factors--result in a disturbed innate (ie, disturbed intestinal barrier, Paneth cell dysfunction, endoplasmic reticulum stress, defective unfolded protein response and autophagy, impaired recognition of microbes by pattern recognition receptors, such as nucleotide binding domain and Toll like receptors on dendritic cells and macrophages) and adaptive (ie, imbalance of effector and regulatory T cells and cytokines, migration and retention of leukocytes) immune response towards a diminished diversity of commensal microbiota. We discuss the epidemiology, immunobiology, amd natural history of Crohn's disease; describe new treatment goals and risk stratification of patients; and provide an evidence based rational approach to diagnosis (ie, work-up algorithm, new imaging methods [ie, enhanced endoscopy, ultrasound, MRI and CT] and biomarkers), management, evolving therapeutic targets (ie, integrins, chemokine receptors, cell-based and stem-cell-based therapies), prevention, and surveillance.

Colonic Diseases↗